关注
Arden Barry
Arden Barry
在 ubc.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult
TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ...
Canadian Journal of Cardiology 32 (11), 1263-1282, 2016
10732016
2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults
GJ Pearson, G Thanassoulis, TJ Anderson, AR Barry, P Couture, N Dayan, ...
Canadian journal of cardiology 37 (8), 1129-1150, 2021
6262021
Familial hypercholesterolemia: Review of diagnosis, screening, and treatment
RD Turgeon, AR Barry, GJ Pearson
Canadian family physician 62 (1), 32-37, 2016
1102016
A systematic review of the effect of CYP3A5 genotype on the apparent oral clearance of tacrolimus in renal transplant recipients
A Barry, M Levine
Therapeutic drug monitoring 32 (6), 708-714, 2010
1082010
Professional use of social media by pharmacists
AR Barry, GJ Pearson
The Canadian journal of hospital pharmacy 68 (1), 22, 2015
532015
Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: a qualitative descriptive study
S Salmasi, L Kwan, J MacGillivray, N Bansback, MA De Vera, AR Barry, ...
Thrombosis Research 173, 109-116, 2019
492019
Patients’ perceptions and use of natural health products
AR Barry
Canadian Pharmacists Journal/Revue Des Pharmaciens Du Canada 151 (4), 254-262, 2018
462018
Pharmacotherapy for heart failure with reduced ejection fraction and health‐related quality of life: a systematic review and meta‐analysis
RD Turgeon, AR Barry, NM Hawkins, UM Ellis
European Journal of Heart Failure 23 (4), 578-589, 2021
452021
Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease
CP Walz, AR Barry, SL Koshman
Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (3), 166-173, 2016
452016
Long‐term beta‐blocker therapy after myocardial infarction in the reperfusion era: a systematic review
J Hong, AR Barry
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (5 …, 2018
422018
Case report and review of clenbuterol cardiac toxicity
AR Barry, MM Graham
Journal of Cardiology Cases 8 (4), 131-133, 2013
352013
Primary prevention of cardiovascular disease in older adults
AR Barry, DE O'Neill, MM Graham
Canadian Journal of Cardiology 32 (9), 1074-1081, 2016
322016
An evaluation of teaching physical examination to pharmacists
AR Barry, L McCarthy, CL Nelson, GJ Pearson
Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 145 (4), 174 …, 2012
322012
Prevention and management of statin adverse effects: A practical approach for pharmacists
AR Barry, JE Beach, GJ Pearson
Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 151 (3), 179-188, 2018
312018
Pharmacotherapy of heart failure with preserved ejection fraction
JE Basaraba, AR Barry
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (4 …, 2015
312015
Adverse drug reactions: The importance of maintaining pharmacovigilance
AR Barry, SL Koshman, GJ Pearson
Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 147 (4), 233-238, 2014
292014
A systematic review of add-on pharmacologic therapy in the treatment of resistant hypertension
AP Tataru, AR Barry
American Journal of Cardiovascular Drugs 17, 311-318, 2017
282017
Influenza vaccination for secondary prevention of cardiovascular events: a systematic review
MH LeBras, AR Barry
The Canadian Journal of Hospital Pharmacy 70 (1), 27, 2017
282017
Longitudinal oral anticoagulant adherence trajectories in patients with atrial fibrillation
S Salmasi, MA De Vera, A Safari, LD Lynd, M Koehoorn, AR Barry, ...
Journal of the American College of Cardiology 78 (24), 2395-2404, 2021
262021
Effect of glucagon-like peptide-1 receptor agonists on all-cause mortality and cardiovascular outcomes: a meta-analysis
SC Peterson, AR Barry
Current Diabetes Reviews 14 (3), 273-279, 2018
222018
系统目前无法执行此操作,请稍后再试。
文章 1–20